A database of publications about African genetic resources and digital sequence information — real bibliographic metadata pulled from PubMed, with a durable link back to the source record. Papers that aren't on PubMed, given by curators as evidence, are listed beside them from Crossref, linked by their DOI to the publisher. Full text is frequently paywalled even when the abstract/metadata is open, so this is a metadata catalog with an outbound link, not a hosted archive; this platform never claims to host or redistribute full text.
Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.
Hensley PJ, Teoh JYC, Li R, Gupta S, Bukavina L, Mouw KW, Lobo N, Maiorano BA, Tan WS, Agarwal P, Al-Ahmadie HA, Bivalacqua TJ, Cheng L, Flaig TW, Guo CC, Horowitz A, Kassouf W, Kates MR, Konety BR, Kukreja JB, Lotan Y, McConkey DJ, Mertens LS, Mir MC, Moschini M, Necchi A, Oualla K, Packiam VT, Schmidt B, Buckley RJ, Kamat AM · Nat Rev Urol (2026)
Morocco · DOI: 10.1038/s41585-026-01179-y
Crucial unmet needs for standardization and clinical integration of actionable biomarkers persist across the bladder cancer disease spectrum. To address these gaps, the International Bladder Cancer Group (IBCG) convened a global multidisciplinary panel to develop evidence-based consensus recommendations on biomarker use in bladder cancer. Recommendations were formulated across the disease spectrum using a modified Delphi process. In patients with asymptomatic microhaematuria, biomarker use should be guided by a risk-stratified approach. For patients with established non-muscle-invasive bladder cancer, no biomarker prospectively validated is available to guide intravesical therapy selection, although approved commercial tests might aid in adjudicating equivocal cytology or cystoscopy findings in patients with high-grade disease. In muscle-invasive bladder cancer, no validated biomarkers exist to guide the choice between bladder preservation and radical cystectomy, or to inform the choice of neoadjuvant therapy. Circulating tumour DNA is prognostic following neoadjuvant therapy and radical cystectomy, and provides predictive value for selecting patients who are most likely to benefit from adjuvant treatment with approved immunotherapy regimens. In addition, circulating tumour DNA has prognostic value in patients with metastatic urothelial carcinoma. The IBCG recommends assessing FGFR3 genomic alterations and HER2 immunohistochemistry in patients with locally advanced and/or metastatic bladder cancer to inform therapeutic selection. The IBCG consensus recommendations provide practical, stage-specific guidance on the use of biomarkers for diagnosis, risk stratification and treatment selection in patients with bladder cancer and define priorities for future validation and trial design.
Designing an integrated data model for prospective genotype-phenotype in inborn errors of immunity research.
Ahmed M, Bousfiha AA, Almarzooqi F · Front Immunol (2026)
Morocco · DOI: 10.3389/fimmu.2026.1838940
Inborn errors of immunity are rare, genetically heterogeneous disorders requiring coordinated clinical, laboratory, and genetic evaluation over time. Data are often fragmented across records, laboratory systems, and genomic reports, limiting longitudinal analysis and coordinated care, particularly in the Middle East and North Africa, where structured rare disease data infrastructures remain limited.
To develop a Research Electronic Data Capture-based data management framework for inborn errors of immunity and demonstrate its use in a prospective multi-site setting.
A Research Electronic Data Capture-based framework was developed at the College of Medicine and Health Sciences, United Arab Emirates University. Modular instruments captured consent, demographics, biospecimen processing, laboratory workflows, and genetic findings within a longitudinal structure. Data dictionaries, validation rules, and conditional logic ensured data quality. The framework was deployed across participating sites for prospective data collection.
The framework enabled integrated longitudinal documentation of enrollment, biospecimens, and genetic testing. It was implemented across two clinical sites and used to enroll patients with suspected or confirmed inborn errors of immunity. The platform supported standardized cross-site data capture and monitoring of genetic findings, including automated flagging of variants of uncertain significance.
This study demonstrates the development and early multi-site implementation of a Research Electronic Data Capture-based framework for inborn errors of immunity. By enabling standardized integration of clinical, laboratory, and genetic data, the platform supports data quality, cross-site collaboration, and tracking of evolving diagnoses. It provides a scalable foundation for rare disease research and may support improved clinical decision-making.
Calibrating tetranucleotide-frequency distances for metagenomic binning with right-skewed distribution models.
Hajjaji O, Al-Soudy AS, Daoud R, Benhida R, Mokhtar MM · Bioinform Adv (2026)
Morocco · DOI: 10.1093/bioadv/vbag207
Metagenomic binning is a pivotal step in reconstructing metagenome-assembled genomes (MAGs) from complex microbial communities, and it critically depends on reliable measures of similarity between contigs. In many workflows, tetranucleotide-frequency (TNF) distances are translated into probabilistic evidence of a shared genome of origin. Despite their central role, these distances are often modeled with convenient but poorly matched assumptions, even though they are intrinsically non-negative and frequently exhibit pronounced right-skewness-features that can distort tail behavior and weaken downstream thresholding decisions. In this work, we introduce a likelihood-based framework for characterizing intra- and inter-genomic TNF distance distributions with flexible right-skewed parametric models and for converting fitted distributions into calibrated distance-to-probability scores within a MaxBin-style scheme. Our approach provides a principled statistical basis for distributional assessment, probability calibration, and transparent operating-point selection, with the goal of improving robustness and interpretability in TNF-driven binning.
All codes related to the article are available through a public GitHub repository at https://github.com/omar-hajjaji/Calibrating-TNF-Distances-for-Metagenomic-Binning-with-Right-Skewed-Distribution-Models.
ß-Globin gene cluster haplotypes in Moroccan sickle cell disease patients: diversity pilot study.
Ismaili FZA, Derkaoui T, Hamjane N, Barakat A, Nourouti NG, Mechita MB · Afr Health Sci (2026)
Morocco · DOI: 10.4314/ahs.v26i2.7
Sickle cell disease (SCD) is the most common inherited blood disorder worldwide. Although monogenic, it presents substantial clinical heterogeneity influenced by genetic modifiers, including haplotypes and fetal hemoglobin (HbF) levels.
This pilot cross-sectional study aimed to characterize, for the first time, the βS gene haplotype distribution among Moroccan patients with sickle cell anemia and evaluate its impact on hematological parameters, particularly HbF levels.
Eight polymorphic sites within the β-globin gene cluster were analyzed using PCR-RFLP in 334 chromosomes from SCD patients in northern Morocco. Associations between haplotypes and HbF levels were evaluated.
PCR RFLP showed that the Benin haplotype was the most common (61.1%), followed by Bantu (14.1%), Atypical A1 (11.7%), Senegal (10.5%), and Arab-Indian (2.7%). The most frequent genotypes were Ben/Ben (41.3%), Ben/CAR (15%), and Ben/Sen (10.2%). HbF levels varied significantly across haplotypes (p < 0.005), with Senegal and Arab-Indian showing the highest levels and Benin and Bantu the lowest.
This study highlights both the genetic and anthropological diversity of SCD in Morocco, likely reflecting historical African gene flow. Haplotype profiling enhances understanding of genotype-phenotype correlations, offering valuable insights for prognosis and individualized care strategies to improve patients' outcomes.
Influence of watershed hydrology on pesticide contamination in coastal waters: insights from Aiguillon Bay (France).
Amchi T, Bouillot A, Saudino A, Zaïr H, Gueret JP, Gallais R, Bazairi H, Maanan M · Environ Sci Pollut Res Int (2026)
Morocco · DOI: 10.1007/s11356-026-38124-w
The transfer of pesticides to Aiguillon Bay, a major coastal ecosystem on the Atlantic coast of France, was investigated in relation to watershed characteristics, agricultural pressure, and hydrological dynamics. The bay receives inputs from three main rivers (Sèvre Niortaise, Lay, and Curé) as well as from the Vieux channel, a downstream branch of the Lay watershed characterized by distinct land-use and drainage features. This study combined spatial land-use analysis with contamination indicators to clarify pesticide transfer pathways and associated ecological risks in intensively cultivated sub-basins. Monthly surface water samples were analyzed using LC-MS/MS and GC-MS/MS. A Proximity Indicator was developed to identify high-pressure agricultural zones adjacent to watercourses. Individual Risk Quotients (RQs) were also calculated by comparing measured environmental concentrations with Predicted No-Effect Concentrations (PNECs) to evaluate the ecological risk associated with selected pesticide compounds, and the Cumulative Toxic Pressure Index (CTPI) was applied to assess mixture toxicity. CTPI analysis revealed recurrent exceedances of the toxicity threshold (CTPI > 1) across all monitored systems, with strong seasonal variability linked to hydrological conditions. The Sèvre Niortaise and Vieux channel exhibited sustained mixture pressure, whereas the Lay showed pronounced event-driven peaks associated with rainfall episodes. Despite its smaller size, the Curé watershed displayed disproportionately high toxic pressure, reflecting strong hydrological connectivity and cereal-dominated land use. Herbicides and their metabolites were the primary contributors to mixture toxicity, including the persistent metabolite chlorothalonil R471811, frequently detected despite its regulatory ban in 2020, suggesting legacy contamination and progressive remobilization. Although individual Risk Quotients indicated negligible ecological risk for the selected compounds, CTPI revealed repeated mixture toxicity exceedances, demonstrating that cumulative effects represent the primary ecological pressure within the watershed. By integrating land-use characterization, hydrological analysis, statistical comparison, mixture toxicity assessment, and ecological risk evaluation, this study provides a comprehensive framework for understanding pesticide transfer to protected coastal ecosystems and supports the development of more effective watershed management and monitoring strategies.
Zhao X, Zeng Y, Xu Y, Rao S, Khouchani M, Soummane H, Li J, Liu R · MedComm (2020) (2026)
Morocco · DOI: 10.1002/mco2.70900
Nucleotide metabolism is a fundamental biochemical process, providing the building blocks for DNA and RNA synthesis while driving critical cellular functions like energy transfer, signal transduction, and coenzyme synthesis. The precise regulation of nucleotide de novo synthesis, salvage, and degradation pathways is imperative for maintaining genomic stability and tissue homeostasis. Aberrations in these networks are increasingly recognized as primary drivers in various pathologies; notably, cancer cells exploit metabolic-functional reprogramming to enable rapid proliferation and therapeutic resistance. Despite the growing recognition of these metabolic vulnerabilities, an integrated understanding of how specific enzymatic dysregulations translate into diverse disease phenotypes remains fragmented. This review systematically synthesizes the physiological regulatory mechanisms governing nucleotide metabolism and describes the molecular underpinnings of its dysregulation across malignant, immune, and neurodegenerative disorders. We critically examine how specific metabolic enzymes are exploited to drive pathogenesis and highlight the complex interplay between nucleotide metabolites and inflammatory or oncogenic signaling cascades. Furthermore, we evaluate recent clinical innovations in precision medicine, focusing on novel inhibitors targeting key metabolic nodes. By mapping these intricate metabolic networks, this article provides a crucial basis for overcoming current therapeutic challenges, offering profound insights to accelerate the development of next-generation targeted therapies.
LTR retrotransposons shape genome architecture, function, and evolution in diverse plant species.
Hassan AH, Mokhtar MM, El Allali A · Front Plant Sci (2026)
Morocco · DOI: 10.3389/fpls.2026.1813217
Long terminal repeat retrotransposons (LTR-RTs) are major components of plant genomes, shaping genome structure and evolution; however, their chromosomal distribution and lineage-specific dynamics remain incompletely understood. Here, we analyzed the abundance, spatial organization, and evolutionary history of intact LTR-RTs across 208 plant species using highquality chromosome-level genomes and the MegaLTR tool. Our analyses reveal extensive interspecific variability in LTR-RTs composition and chromosomal organization. Across families, LTR-RTs distributions are significantly non-random, with chromosome identity strongly influencing accumulation patterns. Although both Copia and Ty3-retrotransposons superfamilies exhibit significant inter-chromosomal heterogeneity, these superfamilies differ in the dimension of their non-randomness: Copia elements show more frequent heterogeneity between chromosomes, while Ty3-retrotransposons display stronger within-chromosome spatial structuring, consistent with preferential accumulation in recombination-suppressed heterochromatic regions. Distinct lineage patterns were observed, including highly structured Ty3-retrotransposons distributions in Poaceae. Insertion time analyses across 16 major clades revealed significant differences between genic and intergenic regions, with most clades showing younger insertions within genes. This pattern supports the role of purifying selection in removing older deleterious insertions from functional sequences. Together, these findings demonstrate that although regulatory mechanisms of LTR-RTs are broadly conserved, their chromosomal landscapes are shaped by superfamily-specific behavior, lineage history, and selective constraints, highlighting the central role of transposable elements in plant genome evolution.
HLA-C polymorphisms with susceptibility and protection against acute leukemia in a Moroccan population.
Laaziri K, Brahim I, Hazime R, Lahlimi FE, Abakarim O, Tazi I, El Bakkouri J, Ettayebi H, Ammara M, Zyad A, Mtairag EM, Admou B · Front Immunol (2026)
Morocco · DOI: 10.3389/fimmu.2026.1869016
Acute leukemia (AL) is a malignant hematological disorder, with two main subtypes: acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). The incidence rate of AML and ALL is estimated at approximately 2.7 and 1.5 per 100,000 people, respectively, with an overall mortality rate of approximately 23.6%. This study aimed to investigate the association between human leukocyte antigen (HLA)-C genotypes and AML and ALL in a Moroccan population.
A cross-sectional and comparative study was conducted on 100 patients with AL including 43 cases of AML and 57 cases of ALL, compared to 120 healthy individuals as controls. HLA-C genotyping was performed in the two groups, using the PCR-SSO (polymerase chain reaction-sequence-specific oligonucleotide)-based technique.
The mean age of the patients was 32 ± 13 (2-62), with a sex ratio of 1.22 (55 male and 45 female patients). In patients with ALL categories, we observed a significantly higher frequency of HLA-C*12 [p = 0.001; odds ratio (OR) = 7.58] allele groups. In the AML category, significant associations were observed between AML and the HLA-C*12 (p = 0.0001; OR = 10.35) and HLA-C*08 (p = 0.005; OR = 8.92) allele groups.
Our findings show a strong association between HLA-C*12 and HLA-C*08 allele groups and AL, including both ALL and AML, which gives evidence of a predisposing effect. This highlights the influence of HLA polymorphism in the occurrence or resistance of AL in our population.
The bacterial microbiota of the spontaneously fermented Ethiopian honey wine, Tej.
Getachew T, Birri DJ, Ashenafi M, Tigu F, Bez C, Bertani I, Venturi V, Desalegn A · J Food Sci Technol (2026)
Morocco · DOI: 10.1007/s13197-025-06372-2
The honey wine ( Tej ) is the most widely consumed traditionally fermented alcoholic beverage in Ethiopia. Different classes of microorganisms including lactic acid bacteria and yeasts have been reported to be involved in its fermentation. The microbial composition of Tej differs based on the raw materials and additives used by the producers. The purpose of this study was to assess the bacterial composition and diversity of Tej . Six Tej samples were collected from small-scale and household Tej producers in Addis Ababa, Ethiopia, and bacterial diversity was analyzed by 16S rRNA amplicon library sequencing. From the examined samples, 68.5% of the sampled Tej had a pH value of ≤ 3.8. The titratable acidity ranged from 0.4 ± 0.1 to 1.2 ± 0.4, with a significant difference observed at p-value = 0.001. The alcohol content (%, v/v) varied between 10.1 ± 0.7 and 12.0 ± 0.9. Firmicutes and Proteobacteria were the two most predominant taxa, with Firmicutes dominating 99.9% of the three Tej samples and being the second most prevalent taxon in the other two samples. The two dominant genera identified were Lactobacillus and Zymomonas. These findings revealed the importance of evaluating the role of different consortia of microorganisms in the production of Tej and assessing its quality.
The online version contains supplementary material available at 10.1007/s13197-025-06372-2.